These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4661290)

  • 21. [Certain problems of antiarrhythmia therapy in myocardial infarct].
    Sivkov II; Kukes VG; Mamedova AD; Rozinov IuI; Maziĭ SA
    Sov Med; 1974 Nov; (11):58-64. PubMed ID: 4439076
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic experiences with LB-46 (a new anti-arrhythmic agent) on arrhythmia during general anesthesia].
    Tosaki Y; Yoshiya I; Yoshikawa K; Onji Y
    Masui; 1971 Jan; 20(1):74-9. PubMed ID: 5102309
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protocol-guide in clinical experimentation on anti-arrhythmia agents].
    Tavazzi L; Sanna GP; Tognoni G; Rizzon P
    G Ital Cardiol; 1985 Jul; 15(7):711-7. PubMed ID: 4076706
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G; Meoli P; Bianchini C; Rovelli F
    G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA; Campos Peris JV; García García J; Jaen Armand E; Ruiz Ros JA; Salas Nieto J; Rodríguez Ruiz P; Marco Quiles J; Martínez Jérez M; Pico Aracil F
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prajmalium bitartrate in the long-term treatment of hyperkinetic ventricular arrhythmias. Preliminary study].
    Molinis G; Valente M; Tuniz D; Maisano G
    Boll Soc Ital Cardiol; 1981; 26(7):657-62. PubMed ID: 7347263
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of cardiac arrhythmias using prajmalium bitartrate in patients with chronic obstructive lung diseases].
    Pantzer M
    Med Welt; 1977 Dec; 28(49):1999-2001. PubMed ID: 600074
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
    von Philipsborn G
    Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 32. [The prevention of arrhythmias in acute myocardial infarct. Use of ajmaline in continuous phleboclysis and of oral disopyramide].
    Selvini A; Ferrari ML; Roda L; Gironi G
    Minerva Med; 1969 May; 60(35):1706-10. PubMed ID: 5790015
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relation between the plasma concentration and anti-arrhythmic effect of di-monochloroacetylajmaline].
    Rossi P; Messina G; Giampaolo P; Cernigliaro C
    G Ital Cardiol; 1974; 4(4):444-9. PubMed ID: 4418006
    [No Abstract]   [Full Text] [Related]  

  • 34. [Verapamil in arrhythmia].
    García Alvarez M; Goñi Marqués J; Cuervo Muñóz C; Baldo Pérez E; Pages Gastaminza I
    Rev Clin Esp; 1978 Oct; 151(2):135-7. PubMed ID: 740981
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiarrhythmic drugs].
    Ben Naceur M; Houissa D
    Tunis Med; 1972; 50(4):305-13. PubMed ID: 4662464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of verapamil in supraventricular arrhythmias of rapid ventricular response].
    De Soldati L; Fuksman A; Rosental R; Mario Krasnov C
    Prensa Med Argent; 1971; 58(13):663-7. PubMed ID: 5566939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value and reliability of new methods of detection of arrhythmia. Evaluation of the efficacity of chloro-acetyl-ajmaline].
    Coumel P; Bouvrain Y; Attuel P
    Sem Hop Ther; 1974 Dec; 50(10):635-42. PubMed ID: 4465912
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.